Dr. Noor Alsaadoun leads biotech and digital health innovation at AlFaisal University in Riyadh. She works at the intersection of science, policy, and technology to create practical tools for care delivery. Her focus includes AI-based diagnostics, inclusive VR platforms, and national data policy infrastructure, all aligned with Saudi Arabia’s Vision 2030.
She also contributes to cross-border research alliances and regulatory frameworks that enable ethical use of health data. Her leadership supports both institutional development and grassroots innovation, with a strong emphasis on access, compliance, and measurable outcomes.
Rooted in Knowledge, Sharpened by Experience
Dr. Alsaadoun holds a Master’s in Medical Sciences (Cancer Genetics) from the University of Calgary, Canada (2012–2018), where she contributed to clinical research in oncology. In 2017, she completed a short fellowship at Japan’s National Cancer Center in Tokyo.
She is currently pursuing an Executive MBA at AlFaisal University (2024–present). Her education also includes a postgraduate programme in Innovation in Healthcare from Harvard University and a diploma in Gaming and Metaverse Technologies from Tuwaiq Academy (2022–2024).
Fellowship and Early Clinical Training
In 2024, she joined the Women Innovators Fellowship at Georgetown University and the Atlantic Council. This fellowship supports Saudi leaders using policy, strategy, and innovation to drive national transformation. Earlier training includes clinical research at Johns Hopkins Aramco Healthcare and the Saudi Organ Donation Center.
Clinical Expertise in Innovation & Digital Health
Innovation systems and policy translation
- Leads Health Innovation Center at AlFaisal University (since 2023)
- Directs Biotech Incubator (since 2022), supporting research-to-market pathways
- Oversees Data Policy Sandbox for compliant AI testing
- Advisor to Ministry of Culture (International Relations Office)
- Board member, ZIMAM (human capital and AI development)
- Participant in Saudi–Japan Expo 2025 and national innovation summits
Digital solutions and inclusive design
- Founder of 21Verse, a VR platform for children with Down syndrome
- Developer of STriage, an AI tool for facial droop detection (stroke indicator)
- Leads national sandbox for privacy-first health data tools
- WiDS (Stanford) Ambassador, supporting women in data science in KSA
A Notable Milestone
In 2024, Dr. Alsaadoun led AlFaisal University’s partnership with MediDent Japan, formalised through a memorandum of understanding at Expo Osaka. This agreement makes AlFaisal the only Saudi university engaged in a strategic research alliance at the event. The initiative focuses on cross-border digital health development and diagnostic tools.
A Career Built on Growth and Academic Leadership
Since joining AlFaisal University in 2022, Dr. Alsaadoun has held multiple concurrent roles. She leads three core programmes: the Health Innovation Center, the Biotech Incubator, and the Data Policy Sandbox. Together, they connect academic research with clinical and commercial application.
She is also active in national innovation programmes, including Misk Foundation, MIT Solve, and the Global Health Exhibition. Her work received the Aramco Innovation Award (2021) and the Sheikh Nahyan Emerging Talent Award (2024). In 2025, she was recognised by HRH Princess Reema Bint Bandar for her contributions to the Women in Innovation Fellowship (George Washington University).
Media & Public Engagement
Dr. Alsaadoun regularly engages with policy and innovation communities:
- Global Health Exhibition 2025 (Riyadh): Panelist on digital equity and AI in health
- Saudi–Japan Expo 2025 (Osaka): Spoke on converting innovation to national investment
- 6th MENA Telehealth Expo (Dubai): Presented AI sandbox model for data compliance
- ALPS Austria Programme: Represented Saudi Arabia in innovation cooperation forum
She brings technical clarity and system design experience to every forum, grounding future-forward ideas in practical models.
Looking Ahead
Dr. Alsaadoun is working to expand STriage into clinical use across Riyadh, launch new content within 21Verse for neurodevelopmental care, and deepen the incubator’s support for Saudi biotech startups. Her priorities include data sovereignty, scalable design, and mentorship for early-career innovators in health-tech. Her focus remains clear: build inclusive tools, support local talent, and align innovation with measurable health outcomes.
Discover more inspiring stories at Founder's Tale where Vision 2030 comes to life.